MedPath

Prevention of premature birth by Nifedipine alone or with Indomethaci

Phase 3
Not yet recruiting
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202004681537890
Lead Sponsor
Mohammed Haider Hassan Ibrahim
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
346
Inclusion Criteria

Women,
aged =18 years,
who diagnosed as threatened preterm labor patient
And their gestational age is between 25 and 34 weeks are eligible for this trial participation.
The diagnosis of threatened preterm labor is defined by uterine contractions, at least 3 contractions per 30 minutes, and one of the following: 1- a cervical length of =10 mm or 2) a cervical length of 11-30 mm 3- ruptured amniotic membranes.
Patients with singleton or twin pregnancies are eligible,
Any fetus position will be included.

Exclusion Criteria

Any condition considered as contra-indication for tocolysis (i.e hypertension or use of anti-hypertensive medication, signs of fetal distress or intrauterine infection, severe vaginal bleeding, myocardial infarction (less than1 month), unstable angina pectoris),
more than 5 cm cervical dilatation,
cerclage,
suspicion in neonatal chromosomal or structural anomalies and tocolytic treatment for more than 6 hours prior to arrival in a participating hospital.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.